Analytical Data
-
基因名
albumin
- Application
-
别名
2S albumin; GM2S-1; Napin-type 2S albumin 3) [Cleaved into: 2S albumin small chain; Aspartic acid-rich peptide; Lunasin); 2S albumin large chain; 8 kDa methionine-rich protein; 8 kDa MRP)]
-
种属
Glycine max
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P19594
-
表达区间
22-158aa
-
分子量
32.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Recombinant albumin, a genetically engineered form of human serum albumin, has gained significant attention in biomedical research and therapeutic applications due to its essential role in maintaining oncotic pressure and transporting various molecules in the bloodstream. Traditional sources of albumin, primarily human plasma, pose several challenges such as supply limitations, risk of viral transmission, and ethical concerns. Consequently, the development of recombinant albumin through microbial fermentation or mammalian cell culture represents a promising alternative. This innovation not only allows for a more consistent and scalable production process but also facilitates the modification of the protein to enhance its stability, half-life, and functional properties. Studies have indicated that recombinant albumin can be engineered to serve specific therapeutic purposes, such as in drug delivery systems, where it acts as a carrier for hydrophobic drugs, or in the formulation of biopharmaceuticals, where it can improve solubility and bioavailability. As research continues to explore its potential, recombinant albumin is paving the way for safer and more effective clinical applications, including in liver diseases, fluid resuscitation, and as a stabilizing agent for various therapeutic proteins, highlighting its growing importance in modern medicine.
